Gyre Therapeutics Inc
(GYRE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 17,898 | -85,480 | 4,314 | -87,933 | -56,241 |
| Depreciation Amortization | 1,588 | 1,114 | 1,129 | 290 | 138 |
| Income taxes - deferred | -1,002 | -1,160 | -838 | N/A | N/A |
| Accounts receivable | -5,257 | 285 | -7,920 | 1,495 | 11,687 |
| Accounts payable and accrued liabilities | -245 | 192 | -112 | 500 | 1,652 |
| Other Working Capital | -15,688 | 7,458 | -7,797 | 483 | -2,572 |
| Other Operating Activity | -935 | 103,483 | 21,901 | 1,410 | -9,712 |
| Operating Cash Flow | $-3,641 | $25,892 | $10,677 | $-83,755 | $-55,048 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,686 | -1,000 | -1,332 | N/A | -97,635 |
| PPE Investments | -1,914 | -7,853 | -4,985 | -839 | -267 |
| Net Acquisitions | N/A | -124 | N/A | N/A | N/A |
| Purchase Of Investment | -15,471 | -15,735 | -7,484 | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 49,028 | 107,565 |
| Purchase Sale Intangibles | -813 | -69 | -13 | N/A | N/A |
| Other Investing Activity | -813 | 4,952 | -13 | 0 | 0 |
| Investing Cash Flow | $-19,884 | $-19,760 | $-13,814 | $48,189 | $9,663 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,638 | N/A | N/A | 49,553 | 60,376 |
| Other Financing Activity | -536 | 2,500 | 0 | 0 | 0 |
| Financing Cash Flow | $2,102 | $2,500 | $N/A | $49,553 | $60,376 |
| Exchange Rate Effect | -273 | -298 | -1,891 | N/A | N/A |
| Beginning Cash Position | 33,509 | 25,175 | 30,203 | 30,360 | 15,369 |
| End Cash Position | 11,813 | 33,509 | 25,175 | 44,347 | 30,360 |
| Net Cash Flow | $-21,696 | $8,334 | $-5,028 | $13,987 | $14,991 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,641 | 25,892 | 10,677 | -83,755 | -55,048 |
| Capital Expenditure | -2,315 | -8,517 | -4,985 | -839 | -267 |
| Free Cash Flow | -5,956 | 17,375 | 5,692 | -84,594 | -55,315 |